|Jorge DiPaola||Executive Committee|
|Wolfgang Bermeier||Executive Committee|
|Kristy Lee, MS, CGC||Coordinator|
|Leighton Telling, BS||Coordinator|
|Andrew D Mumford BSc MB ChB PhD FRCPath||Member|
|Minjie Luo, PhD||Member|
|Gabriella Ryan, Ph.D.||Member|
|Juliana Perez Botero||Member|
|Bing Melody Zhang||Member|
|Shruthi Mohan, Ph.D.||Member|
Please contact a coordinator if you have questions.
A systematic process of evaluating evidence to classify a genomic variant on a spectrum from pathogenic to benign with respect to a particular disease and inheritance pattern.